World Health Organisation’s Bacterial Pathogen Priority List (BPPL) 2017 and BPPL 2024 to combat global antimicrobial resistance crisis: ‘challenges and opportunities’ DOI

Vazhayil Hari Krishnaprasad,

Vijayashree Nayak, Sanjay Kumar

и другие.

Journal of Antimicrobial Chemotherapy, Год журнала: 2025, Номер unknown

Опубликована: Май 27, 2025

Abstract Antibiotic resistance, in a broader perspective, antimicrobial resistance (AMR) presents formidable global health challenge, threatening the effectiveness of antibiotics and other agents. As result, AMR has become more challenging or even impossible to treat, leading increased morbidity mortality. The World Health Organisation (WHO) been at forefront international efforts combat by sensitizing world about pressing need tackle save future human race. This article analyses WHO’s AMR, including creating Bacterial Pathogen Priority List (BPPL), developing action plan address promoting surveillance stewardship programmes. also examines progress achieved BPPL 2017 challenges ahead for 2024. Additionally, this explores various through two major approaches, like ‘research development’ ‘the policy regulation-based’ approach. underscores emerging strategies example, biofilm disruption, nanotechnology, antibiotic breakers, antibody-antibiotic conjugates, rapid detection tools alternative therapies phage therapy, peptides, CRISPR-Cas system, probiotics microbiota modulations. highlights importance coordinated actions sustained commitment safeguarding public ensuring continued therapies.

Язык: Английский

Structural characteristics, functions, and counteracting strategies of biofilms in Staphylococcus aureus DOI Creative Commons

Yi-qi Xia,

Zhenghui Hu,

Qiyuan Jin

и другие.

Computational and Structural Biotechnology Journal, Год журнала: 2025, Номер 27, С. 488 - 500

Опубликована: Янв. 1, 2025

Staphylococcus aureus (S. aureus) is a prevalent pathogen associated with wide range of infections, exhibiting significant antibiotic resistance and posing therapeutic challenges in clinical settings. The formation biofilms contributes to the emergence resistant strains, further diminishing efficacy antibiotics. This, turn, leads chronic recurrent ultimately increasing healthcare burden. Consequently, preventing eliminating has become critical focus management research. This review systematically examines mechanisms underlying biofilm S. its contribution resistance, emphasizing essential roles play maintaining structural integrity enhancing resistance. It also analyses protective that fortify against antimicrobial treatments. Furthermore, provides comprehensive overview recent innovations, including enzymatic therapy, nanotechnology, gene editing, phage therapy. Emerging strategies present novel approaches combat biofilm-associated infections through various mechanisms. discusses advancements these therapies, their practical application, an in-depth analysis each strategy's potential. By mapping future research directions, this aims refine anti-biofilm control infection progression effectively mitigate recurrence.

Язык: Английский

Процитировано

1

Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria DOI Creative Commons

Junze Ma,

Zheng Lu

Microorganisms, Год журнала: 2025, Номер 13(1), С. 172 - 172

Опубликована: Янв. 15, 2025

The pervasive and often indiscriminate use of antibiotics has accelerated the emergence drug-resistant bacterial strains, thus presenting an acute threat to global public health. Despite a growing acknowledgment severity this crisis, current suite strategies mitigate antimicrobial resistance remains markedly inadequate. This paper asserts paramount need for swift development groundbreaking provides comprehensive review array innovative techniques currently under scrutiny. Among these, nano-antimicrobials, antimicrobials derived from ribosomal proteins, CRISPR/Cas-based systems, agents that undermine bioenergetics, polysaccharides hold particular promise. analysis gives special attention antimicrobials, scrutinizing their underlying mechanisms, exploring potential applications, delineating distinct advantages, noting likely limitations. Furthermore, we extend our exploration by proposing theoretical advancements in technology evaluating feasible methods effective delivery these agents. includes leveraging advances broader biomedical potentially revolutionizing how confront pathogens future, laying foundation extended research multimodal therapeutic strategies.

Язык: Английский

Процитировано

0

Carbapenem-resistant hypervirulent Klebsiella pneumoniae: where is it headed in the tug-of-war between virulence and resistance? DOI Creative Commons
Meng Wang, Hui Wang

EBioMedicine, Год журнала: 2025, Номер 114, С. 105649 - 105649

Опубликована: Март 10, 2025

Язык: Английский

Процитировано

0

Genome Editing: An Approach to Engineer Crops to Withstand Climate Change and Sustain Food Security DOI
Othman Al‐Dossary

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Advancements in CRISPR-Cas-Based Strategies for Combating Antimicrobial Resistance DOI
Ruiting Zhang, Qi Zhou,

Siying Huang

и другие.

Microbiological Research, Год журнала: 2025, Номер 298, С. 128232 - 128232

Опубликована: Май 22, 2025

Язык: Английский

Процитировано

0

World Health Organisation’s Bacterial Pathogen Priority List (BPPL) 2017 and BPPL 2024 to combat global antimicrobial resistance crisis: ‘challenges and opportunities’ DOI

Vazhayil Hari Krishnaprasad,

Vijayashree Nayak, Sanjay Kumar

и другие.

Journal of Antimicrobial Chemotherapy, Год журнала: 2025, Номер unknown

Опубликована: Май 27, 2025

Abstract Antibiotic resistance, in a broader perspective, antimicrobial resistance (AMR) presents formidable global health challenge, threatening the effectiveness of antibiotics and other agents. As result, AMR has become more challenging or even impossible to treat, leading increased morbidity mortality. The World Health Organisation (WHO) been at forefront international efforts combat by sensitizing world about pressing need tackle save future human race. This article analyses WHO’s AMR, including creating Bacterial Pathogen Priority List (BPPL), developing action plan address promoting surveillance stewardship programmes. also examines progress achieved BPPL 2017 challenges ahead for 2024. Additionally, this explores various through two major approaches, like ‘research development’ ‘the policy regulation-based’ approach. underscores emerging strategies example, biofilm disruption, nanotechnology, antibiotic breakers, antibody-antibiotic conjugates, rapid detection tools alternative therapies phage therapy, peptides, CRISPR-Cas system, probiotics microbiota modulations. highlights importance coordinated actions sustained commitment safeguarding public ensuring continued therapies.

Язык: Английский

Процитировано

0